Four neuromuscular specialists share their invaluable real-world experiences in treating CIDP.

Join Dr. England, Dr. Katz, Dr. Levine, and Dr. Muley as they share their invaluable real-world experiences in treating Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This discussion will delve into the critical pathophysiological factors influencing treatment options, including the use of IVIG and FcRn inhibitors. Discover insights that will shape your understanding and approach to optimally managing CIDP.